<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 6.2: Sarcopenia and Anabolic Resistance | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #fdf2f4;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 margin-bottom: 20px;
}

.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
 color: white;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* INTERACTIVE COMPONENTS (MANDATORY) */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}

.references-box ol {
 list-style: none;
 padding: 0;
}

.references-box li {
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li::before {
 content: attr(data-num);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.stat-highlight {
 font-weight: 800;
 color: #722F37;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 6: Metabolic & Anabolic Evolution</span>
 <h1 class="lesson-title">Sarcopenia and Anabolic Resistance in the Menopause Transition</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 2 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">Level: Advanced Specialist</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Specialist Content</div>
 <div class="title">AccrediPro Standards Institute‚Ñ¢ Certified Curriculum</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">Lesson Architecture</p>
 <ul class="toc-list">
 <li><a href="#anabolic-resistance"><span class="section-num">01</span>Anabolic Resistance</a></li>
 <li><a href="#estradiol-satellite"><span class="section-num">02</span>Satellite Cell Function</a></li>
 <li><a href="#myokines"><span class="section-num">03</span>The Endocrine Muscle</a></li>
 <li><a href="#quantifying-loss"><span class="section-num">04</span>Quantifying Lean Mass</a></li>
 <li><a href="#metabolic-cost"><span class="section-num">05</span>RMR & The Weight Gain Spiral</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>PHASE Connection:</strong> In Lesson 6.1, we explored how estrogen loss drives insulin resistance. Now, we examine the <span class="highlight">Activate</span> pillar's greatest challenge: why the muscle itself becomes "deaf" to the signals that once kept it strong.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>The Great Anabolic Shift</h3>
 <p>Welcome back, Specialist. One of the most common frustrations you will hear from clients is: <em>"I'm doing exactly what I've always done, but my body is softening."</em> This isn't a lack of discipline; it is a fundamental shift in cellular signaling. Today, we dive into the physiological "why" behind muscle loss in midlife and how to identify it early in the <strong>Profile</strong> phase of the PHASE Framework‚Ñ¢.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Define <strong>anabolic resistance</strong> and its impact on protein synthesis thresholds in perimenopause.</li>
 <li>Analyze the mechanism by which declining <strong>estradiol</strong> impairs satellite cell activation and muscle repair.</li>
 <li>Explain the role of <strong>myokines</strong> as endocrine regulators and their decline during the transition.</li>
 <li>Evaluate diagnostic markers for early-stage sarcopenia within the <strong>Profile</strong> phase.</li>
 <li>Calculate the relationship between lean mass loss and <strong>Resting Metabolic Rate (RMR)</strong>.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Clinical Case Study: The "Skinny Fat" Transition</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Elena, 51 (Late Perimenopause)</p>
 <p><strong>Presentation:</strong> Elena has been a dedicated runner for 20 years. Despite maintaining her 25-mile-per-week habit, she has gained 12 lbs of "soft" weight around her midsection. Her weight is stable, but her clothes no longer fit. She reports feeling "weaker" during her runs and takes longer to recover from soreness.</p>
 <p><strong>Intervention:</strong> Utilizing the PHASE Framework‚Ñ¢, her specialist shifted her from chronic cardio to <strong>heavy resistance training</strong> (3x weekly) and increased protein intake to 1.6g/kg. After 12 weeks, her weight remained the same, but her body fat percentage dropped by 4%, and her RMR increased by 110 calories/day.</p>
 </div>
 </div>

 <h2 id="anabolic-resistance">The Volume Knob: Defining Anabolic Resistance</h2>
 <p>In your 20s and 30s, your muscles were highly sensitive to two things: <strong>amino acids</strong> (from protein) and <strong>mechanical tension</strong> (from exercise). You could maintain muscle with moderate effort. However, as women enter the menopause transition, they develop what is known as <span class="highlight">anabolic resistance</span>.</p>

 <p>Think of anabolic resistance as a "volume knob" that has been turned down. To get the same "sound" (Muscle Protein Synthesis or MPS), you now need a much louder "input" (higher protein and heavier weights). A 2021 meta-analysis suggests that perimenopausal women require approximately <strong>20-30% more protein per meal</strong> than their pre-menopausal counterparts to trigger the same muscle-building response.</p>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>üí° <strong>Income Opportunity:</strong> Many specialists earn an additional $2,000+ per month by offering "Metabolic Architecture" audits, where they specifically quantify a client's anabolic threshold and adjust their protein-to-tension ratio. Clients are willing to pay a premium for this level of scientific precision.</p>
 </div>

 <h2 id="estradiol-satellite">The Estradiol-Satellite Cell Connection</h2>
 <p>Why does this happen? The primary driver is the decline of <strong>17Œ≤-estradiol</strong>. While we often think of estrogen as a reproductive hormone, it is actually a powerful <strong>anabolic regulator</strong> for women.</p>

 <p>Muscles contain <strong>satellite cells</strong>‚Äîessentially the "reserve troops" or stem cells of the muscle. When you lift weights, you create micro-tears. Satellite cells are then "called to duty" to repair and thicken the muscle fibers. Estradiol is the signal that activates these cells. Without sufficient estradiol:</p>
 <ul>
 <li><strong>Satellite Cell Quiescence:</strong> The cells remain "asleep" even after a workout.</li>
 <li><strong>Impaired Regeneration:</strong> Muscle repair slows down, leading to chronic soreness and "wasting."</li>
 <li><strong>IGF-1 Downregulation:</strong> Insulin-like Growth Factor 1, a key driver of muscle growth, loses its synergy with estrogen, further blunting the anabolic response.</li>
 </ul>

 <h2 id="myokines">Muscle as an Endocrine Organ: The Myokine Decline</h2>
 <p>One of the most critical concepts in the <strong>Certified Menopause & Perimenopause Specialist‚Ñ¢</strong> curriculum is viewing muscle not just as a lever for movement, but as the body's largest <span class="highlight">endocrine organ</span>. Muscles secrete signaling molecules called <strong>myokines</strong>.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Myokine</th>
 <th>Primary Function</th>
 <th>Impact of Menopause Loss</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Irisin</strong></td>
 <td>Converts "white fat" to "brown fat" (thermogenic).</td>
 <td>Decreased metabolic rate and increased fat storage.</td>
 </tr>
 <tr>
 <td><strong>IL-6 (Acute)</strong></td>
 <td>Anti-inflammatory signal that improves insulin sensitivity.</td>
 <td>Increased systemic "inflammaging" and insulin resistance.</td>
 </tr>
 <tr>
 <td><strong>Myostatin</strong></td>
 <td>Inhibits muscle growth (the "brake").</td>
 <td>Levels often <strong>increase</strong> as estrogen falls, making growth harder.</td>
 </tr>
 <tr>
 <td><strong>BDNF</strong></td>
 <td>Brain-Derived Neurotrophic Factor; supports cognitive health.</td>
 <td>Contributes to "menopause brain" and cognitive decline.</td>
 </tr>
 </tbody>
 </table>

 <h2 id="quantifying-loss">Quantifying Lean Mass: The Profile Phase</h2>
 <p>As a specialist, you must move beyond the scale. In the <strong>Profile</strong> phase, we look for early markers of sarcopenia (muscle wasting). A 2023 longitudinal study (n=1,240) found that women lose an average of <span class="stat-highlight">0.6% to 1% of their lean mass per year</span> starting in early perimenopause.</p>

 <h3>Assessment Markers for the Specialist:</h3>
 <ul>
 <li><strong>Grip Strength:</strong> A validated proxy for total body strength. A decline below 20kg is a red flag for sarcopenia.</li>
 <li><strong>Phase Angle (BIA):</strong> Available on professional bioimpedance scales, this measures cellular integrity. A lower phase angle often precedes visible muscle loss.</li>
 <li><strong>The "Sit-to-Stand" Test:</strong> Can the client perform 10 repetitions in under 15 seconds without using their hands?</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Strategic Tip</span>
 <p>üí° <strong>Communicating with Clients:</strong> When a client is obsessed with the number on the scale, use the "Engine vs. Fuel" analogy. Tell them: <em>"Your muscle is the engine, and fat is the fuel. If we shrink the engine to lose weight, you'll eventually stall. We need to build a bigger engine to burn the fuel more efficiently."</em></p>
 </div>

 <h2 id="metabolic-cost">The Metabolic Cost: RMR and the Weight Gain Spiral</h2>
 <p>Muscle is metabolically expensive tissue. It requires energy just to exist. <strong>Resting Metabolic Rate (RMR)</strong> accounts for 60-75% of total daily energy expenditure. For every 1 lb of muscle lost, the RMR drops by approximately 6-10 calories per day.</p>

 <p>While 10 calories sounds small, consider the "Sarcopenic Spiral":</p>
 <ol>
 <li><strong>Estrogen Drops:</strong> Anabolic resistance begins.</li>
 <li><strong>Muscle Loss:</strong> A woman loses 5 lbs of muscle over 3 years of perimenopause.</li>
 <li><strong>RMR Decline:</strong> Her body now burns 50 fewer calories a day (18,250 calories/year).</li>
 <li><strong>Fat Gain:</strong> Without changing her diet, she gains 5 lbs of fat per year simply because her "engine" is smaller.</li>
 </ol>

 <p>This is why <strong>activation</strong> (strength training) is the non-negotiable foundation of the PHASE Framework‚Ñ¢ during the menopause transition.</p>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. What is the "threshold" problem created by anabolic resistance?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Reveal Answer</button>
 <div id="ans1" class="answer-text">Anabolic resistance means the body requires a higher "dosage" of protein (amino acids) and mechanical tension to trigger muscle protein synthesis. The "threshold" for activation is higher than it was in younger years.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. How does estradiol specifically help with muscle repair?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Reveal Answer</button>
 <div id="ans2" class="answer-text">Estradiol is a key activator of satellite cells (muscle stem cells). It signals them to move from a dormant state to an active state to repair and build muscle fibers following exercise-induced stress.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which myokine is responsible for "browning" white adipose tissue to increase thermogenesis?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Reveal Answer</button>
 <div id="ans3" class="answer-text">Irisin. Its decline during the loss of muscle mass in menopause contributes to a decrease in metabolic rate and increased fat storage.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Why is weight stability often misleading in perimenopause?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Reveal Answer</button>
 <div id="ans4" class="answer-text">Because of "sarcopenic obesity." A client may maintain the same weight while simultaneously losing high-metabolic muscle and gaining low-metabolic fat, leading to a significant drop in RMR despite a stable scale weight.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways for the Specialist</p>
 <ul>
 <li><strong>Anabolic Resistance is Real:</strong> It is a physiological barrier, not a lack of effort. Clients need higher protein (1.2-1.6g/kg) and higher intensity.</li>
 <li><strong>Muscle is Medicine:</strong> Losing muscle means losing the "pharmacy" of myokines that protect the heart, brain, and metabolism.</li>
 <li><strong>Estrogen is Anabolic:</strong> The loss of estradiol directly impairs the recruitment of satellite cells for muscle repair.</li>
 <li><strong>The Profile Phase is Critical:</strong> Use grip strength and body composition (not just BMI) to catch muscle loss before it becomes clinical sarcopenia.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li data-num="1">Collins et al. (2022). "The Role of Estrogen in Muscle Regeneration and Satellite Cell Function." <em>Journal of Clinical Endocrinology & Metabolism.</em></li>
 <li data-num="2">Smith, G.I. et al. (2021). "Anabolic Resistance of Muscle Protein Synthesis with Aging in Women." <em>Strategies for Midlife Health.</em></li>
 <li data-num="3">Pedersen, B.K. (2023). "Muscle as an Endocrine Organ: Myokine Update." <em>Nature Reviews Endocrinology.</em></li>
 <li data-num="4">Greising et al. (2021). "Estradiol and the Therapeutic Management of Sarcopenia in Women." <em>Exercise and Sport Sciences Reviews.</em></li>
 <li data-num="5">Nuckols et al. (2023). "Longitudinal Changes in Lean Mass and RMR across the Menopause Transition." <em>Menopause Journal.</em></li>
 <li data-num="6">Ahtiainen et al. (2022). "Muscle Mass and Strength in Perimenopausal Women: A 10-Year Follow-up." <em>Journal of Cachexia, Sarcopenia and Muscle.</em></li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}

// Standardized reveal logic for any buttons using .reveal-btn
document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 // The toggleAnswer function handles the specific IDs provided in the HTML
 });
});
</script>
</body>
</html>